Heritage
Foundations
​
Cann Pharmaceutical Australia (CPA) was launched in 2016 - and was the first Australian company to obtain a joint venture with a licensed medicinal cannabis company in Israel - Cann Pharmaceutical Ltd of Israel. CPA was founded with the goal of breaking into the international market for the provision of medicinal cannabis treatments to children with epilepsy.​
​
In Australia, CPA's management, board of directors and advisors consist of proven business, academic and medical leaders with extensive histories of achievement in the medicinal cannabis sector, clinical research, and biotechnology.
​
Collectively, the team's breadth of experience ranges from advanced agribusiness technology, biotechnology, healthcare and the pharmaceutical sectors, plus proven entrepreneurial and business development in Australia and Israel.
​
Certifications
​
CPA's certifications include the issuing of a License for Medicinal Cannabis Cultivation and Production from the Office of Drugs Control (ODC) in 2017, and the issuing of a License for Medicinal Cannabis Manufacturing in 2019.